Covered recipient · General Payments record
PAUL NORWOOD
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$32,177.90
- Reported across 753 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,498.21 | 71 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $252.64 | 13 |
| Lilly USA, LLC | $247.23 | 23 |
| Abbott Laboratories | $179.68 | 9 |
| Lexicon Pharmaceuticals, Inc. | $124.90 | 1 |
| Saluda Medical Americas, Inc. | $101.19 | 1 |
| Tandem Diabetes Care, Inc. | $94.73 | 3 |
| Alexion Pharmaceuticals, Inc. | $94.55 | 3 |
| MannKind Corporation | $44.08 | 2 |
| Ascensia Diabetes Care US Inc. | $41.72 | 2 |
| Amgen Inc. | $31.13 | 1 |
| Kyowa Kirin, Inc. | $29.76 | 1 |
| GENZYME CORPORATION | $28.40 | 1 |
| Radius Health, Inc. | $27.36 | 1 |
| Ultragenyx Pharmaceutical Inc. | $24.17 | 1 |
| CeQur Corporation | $24.00 | 1 |
| DEXCOM, INC. | $23.78 | 1 |
| PFIZER INC. | $22.59 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.67 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.32 | 1 |
| SANOFI-AVENTIS U.S. LLC | $18.34 | 1 |
| SANOFI PASTEUR INC. | $16.14 | 1 |
| Amphastar Pharmaceuticals, Inc. | $15.45 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (71)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.